• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Clin Lab Anal . Association between serum inflammatory parameters and the disease severity in COVID-19 patients

tetano

Editor, Senior Moderator
J Clin Lab Anal


. 2021 Dec 7;e24162.
doi: 10.1002/jcla.24162. Online ahead of print.
Association between serum inflammatory parameters and the disease severity in COVID-19 patients


Rajab Mardani[SUP] 1 [/SUP], Mehrnoush Namavar[SUP] 2 [/SUP], Elham Ghorbi[SUP] 2 [/SUP], Zabihollah Shoja[SUP] 3 [/SUP], Fatemeh Zali[SUP] 4 [/SUP], Hooman Kaghazian[SUP] 2 5 [/SUP], Mohammad Reza Aghasadeghi[SUP] 2 6 [/SUP], Seyed Amir Sadeghi[SUP] 2 6 [/SUP], Shahram Sabeti[SUP] 7 [/SUP], Ilad Alavi Darazam[SUP] 8 [/SUP], Nayebali Ahmadi[SUP] 9 [/SUP], Seyed Dawood Mousavi-Nasab[SUP] 2 5 [/SUP]



Affiliations

Abstract

Objective: Most patients infected with the novel coronavirus (SARS-CoV-2), as the causative agent of COVID-19 disease, show mild symptoms, but some of them develop severe illness. The purpose of this study was to analyze the blood markers of COVID-19 patients and to investigate the correlation between serum inflammatory cytokines and the disease severity.
Methods: In this prospective cross-sectional study, 50 patients with COVID-19 and 20 patients without COVID-19 were enrolled. According to ICU admission criteria, patients were divided into two groups of non-severe and severe. Differences in the serum levels of C-reactive protein (CRP), IL-6, and TNF-α, as well as erythrocyte sedimentation rate (ESR), lymphocytes (LYM) count, and neutrophils (NEU) count between the two groups were determined and analyzed.
Results: Out of the 50 patients with COVID-19, 14 were diagnosed as severe cases. There was no significant difference between the two groups of COVID-19 patients in terms of gender and age. Blood tests of COVID-19 patients showed a significant decrease and increase in NEU and LYM counts, respectively. There were significant differences in the serum levels of IL-6, TNF-α, and CRP between the severe and non-severe groups, which were higher in the severe group. Also, there was a significant correlation between the disease severity and CRP with ESR (r = 0.79), CRP with IL-6 (r = 0.74), LYM with NEU (r = -0.97), and ESR with TNF-α (r = 0.7).
Conclusion: The findings of this study, as the first study in Iran, suggest that the levels of IL-6, TNF-α, ESR, and CRP could be used to predict the severity of COVID-19 disease.

Keywords: COVID-19; CRP; IL-6; SARS-CoV-2; TNF-α; cytokines.
 
Back
Top Bottom